65,437 trials
Squamous Cell Carcinoma of the Oropharynx · Squamous Cell Carcinoma of the Larynx · Squamous Cell Carcinoma of the Oral Cavity
Primary: Phase I: Maximum Tolerated Dose — 500 mg/m^2
Psoriasis
Primary: The Number of Participants With a Static Physician's Global Assessment (sPGA) Score of 0 or 1 in Participants Receiving BMS-986165 Compared to Placebo at Week 16 (sPGA…
HIV-1-infection
Primary: Percentage of Participants With HIV-1 RNA < 50 Copies/mL as Determined by the FDA-defined Snapshot Algorithm — 32 Participants
Alcohol-related Liver Disease
Primary: Adverse Event — 0; 1 adverse events
Obesity · Labor, Induced · Oxytocin
Primary: Length of Time to Delivery — 796; 694; 715; 762 minutes
Obstetric Pain · Postpartum Depression · Breastfeeding
Primary: Ketamine (AUC) — 28.46 mcg*min/mL
Anesthesia · Surgery
Primary: Oropharyngeal Leak Pressure (OLP) — 20.9; 22.6 cm H20
Skin Smoothness of the Cheeks
Primary: Percentage of Participants With at Least 1-point Improvement (Decrease) From Baseline on the Allergan Cheek Smoothness Scale (ACSS) on Both Cheeks at Month 1 — 4.5; 57.9…
Leukemia · T-cell Prolymphocytic Leukemia (T-PLL) · Cancer
Primary: Overall Response Rate (ORR) — 7.1 percentage of participants
COVID-19
Primary: Number of Participants Meeting Criteria for Each of the 8 Ordinal Scale Categories on Day 8 — 15; 21; 36; 36 Participants — p=0.927
Psoriasis · Plaque Psoriasis
Primary: Mean Percentage Change in PASI — -14.39; -20.37; -22.73; -23.49 percentage of change
Hepatitis C · HIV Infections · Opioid-use Disorder
Primary: Acceptability of Intervention — 13; 6; 0; 0 Participants
HIV-1-infection
Primary: Percentage of Participants With Human Immunodeficiency Virus-1 Ribonucleic Acid (HIV-1 RNA) < 50 Copies/mL at Week 54 as Determined by the United States Food and Drug…
Psoriatic Arthritis
Primary: Change From Baseline in the Composite Score of BME, Synovitis, and Tenosynovitis Assessed by PsAMRIS at Week 24 — -2.32 score on a scale
Chronic Lymphocytic Leukemia
Primary: Overall Response Rate (ORR) — 64.8; 69.4 percentage of participants